| __timestamp | Bausch Health Companies Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 55430000 |
| Thursday, January 1, 2015 | 582800000 | 65510000 |
| Friday, January 1, 2016 | 455000000 | 71160000 |
| Sunday, January 1, 2017 | 366000000 | 70644000 |
| Monday, January 1, 2018 | 414000000 | 70418000 |
| Tuesday, January 1, 2019 | 471000000 | 63238000 |
| Wednesday, January 1, 2020 | 452000000 | 59777000 |
| Friday, January 1, 2021 | 465000000 | 60152000 |
| Saturday, January 1, 2022 | 529000000 | 54540000 |
| Sunday, January 1, 2023 | 604000000 | 52243000 |
| Monday, January 1, 2024 | 64536000 |
Data in motion
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bausch Health Companies Inc. and Taro Pharmaceutical Industries Ltd. have demonstrated contrasting approaches to R&D investment. Bausch Health has consistently allocated a significant portion of its budget to R&D, with expenditures peaking in 2023 at approximately 604 million USD, marking a 145% increase from 2014. In contrast, Taro Pharmaceutical's R&D spending has remained relatively stable, with a slight increase of around 16% over the same period, reaching about 65 million USD in 2024. This disparity highlights Bausch Health's aggressive strategy to drive innovation, while Taro Pharmaceutical maintains a more conservative approach. The data from 2024 is incomplete for Bausch Health, indicating potential shifts in strategy. These insights offer a glimpse into how these companies prioritize innovation in a rapidly evolving industry.
Novo Nordisk A/S or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Biogen Inc. and Bausch Health Companies Inc.
Dr. Reddy's Laboratories Limited or Bausch Health Companies Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Bio-Techne Corporation vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and Taro Pharmaceutical Industries Ltd.
Analyzing R&D Budgets: TG Therapeutics, Inc. vs Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
R&D Insights: How Taro Pharmaceutical Industries Ltd. and Novavax, Inc. Allocate Funds
Research and Development Expenses Breakdown: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.